Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-122084
Filing Date
2024-11-06
Accepted
2024-11-06 14:08:57
Documents
1
Period of Report
2024-11-04

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 5518
  Complete submission text file 0000950170-24-122084.txt   7150
Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Issuer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 7100 WEST CREDIT AVENUE, SUITE 101 MISSISSAUGA A6 L5N OE4
Business Address
Kaseta Michael (Reporting) CIK: 0001724346 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33221 | Film No.: 241430219